PacBio’s Sequel IIe Selected by Prenetics to Build Personalized Genomics for Healthcare
Leading global genomics and diagnostic testing firm adds more comprehensive genetic information to its services…
Month: November 2021
Turning Point Therapeutics to Host Third Quarter 2021 Conference Call
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
MacroGenics Provides Update on Corporate Progress and Third Quarter 2021 Financial Results
Investigational New Drug (IND) application submitted for MGD024, a next generation DART® molecule targeting CD123…
Biofrontera Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Warrants
WOBURN, MA., Nov. 02, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (“Biofrontera” or the “Company”) (Nasdaq:…
Tauriga Sciences, Inc. to Proceed with the Production of its Proprietary Kratom Infused Chewing Gum
1) CORRECT Image of Kratom PR Blister Pack Design for Kratom Infused version of Tauri-Gum™…
Number of voting rightts as of October 31
Nicox SA Société anonyme with a registered capital of € 37,138,185 Head Office: DRAKKAR…
Tricida to Report Third Quarter Financial Results and Host Conference Call and Webcast on Monday, November 8, 2021
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA) today announced…
Rapid Therapeutic Science Laboratories Adds Two Independent Directors to Company’s Board
Company Fulfills Important Nasdaq Requirements with Appointment of Dr. Henry Punzi and Justin Suggs as…
Todos Medical Sees Significant Ramp Up in COVID PCR Testing Volume at Its Provista CLIA/CAP Lab with New Automation in Place
Automation enabled Provista to conduct over 7,600 PCR tests for the month of October, more…
Manager’s transactions
Company announcement no. 13/2021November 2, 2021 Please see attachment. For further information please contact:Anders Mohr…
AXIM Biotechnologies Appoints Clinical Research and DED Expert Dr. Michael E. Stern to its Medical Advisory Board
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or…
ALX Oncology Announces Upcoming Virtual Investor Conference Participation
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX…
Mountain Valley MD Holdings Completes Licensing Agreement With Red White and Bloom Brands Inc.
TORONTO, Nov. 02, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
HMNC Brain Health to Participate in Microdose’s Wonderland: Miami Conference on November 8-9, 2021
MUNICH, Germany, Nov. 02, 2021 (GLOBE NEWSWIRE) — HMNC Brain Health (“HMNC” or the “company”),…
Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum
– Mr. Johnson brings broad commercial expertise with over 30 years of leadership spanning dermatology…
Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences
SUZHOU, China and PALO ALTO, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc….
CorMedix Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on November 9
BERKELEY HEIGHTS, N.J., Nov. 02, 2021 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Atreca Reports Third Quarter 2021 Financial Results and Recent Corporate Developments
SAN CARLOS, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…
Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans
Highlights: Revenue of $167.3 million up 15% year-over-year. Excluding revenue from divested businesses, revenue increased…
Quoin Pharmaceuticals Announces Signing of Exclusive License from Queensland University of Technology, Australia
Addition of Bi-Functional Protein Is Complementary to Lead Asset QRX003 for Netherton Syndrome ASHBURN, Va.,…